Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €1.90 EUR
Change Today +0.216 / 12.86%
Volume 0.0
IM3 On Other Exchanges
As of 3:38 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gerard G. Gorman

AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2014


Mr. Gerard G. Gorman served as the Chief Financial Officer of Immunomedics Inc., since September 2001 until September 3, 2013 and its Senior Vice President of Business Development & Finance since June 2006 until September 3, 2013 and also its Principal Accounting Officer until September 3, 2013. Mr. Gorman served as Treasurer of IBC Pharmaceuticals Inc., a Majority owned subsidiary of Immunomedics Inc. He served as Vice President of Finance of Immunomedics since September ...

Read Full Background

Corporate Headquarters*

300 The American Road
Morris Plains, New Jersey 07950

United States

Phone: 973-605-8200
Fax: 973-605-8282

Board Members Memberships*

There is no Board Members Memberships data available.


Fairfield University
Adelphi University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$56,636

Stock Options*

All Other Compensation$233,322
Exercisable Options371,225
Total Number of Options371,225

Total Compensation*

Total Annual Cash Compensation$289,958
Total Short Term Compensation$56,636
Other Long Term Compensation$233,322
Total Calculated Compensation$818,853
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IM3:GR €1.90 EUR +0.216


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUNOMEDICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at